Dr. Danh-Tai Hoang. Credit: The Australian National University (ANU). A new artificial intelligence (AI) tool that can help physicians to select the most suitable treatment for cancer patients has been developed by researchers at The Australian National University (ANU). DeepPT, developed in collaboration with scientists at the National Cancer Institute in America and pharmaceutical company Pangea Biomed, works by predicting a patient’s messenger RNA (mRNA) profile. This mRNA—essential for protein production—is also the key molecular information for personalized cancer medicine. The work appears in Nature Cancer. According to lead author Read More